_id
69105d03ccc777a4e85d5892
Ticker
DRTSW
Name
Alpha Tau Medical Ltd. Warrant
Exchange
NASDAQ
Address
Kiryat HaMada St. 5, Jerusalem, Israel, 9777605
Country
USA
Sector
Industry
Currency
USD
Website
https://www.alphatau.com
Description
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
Last Close
0.3251
Volume
20369
Current Price
0.43
Change
-0.015
Last Updated
2026-01-02T12:49:14.116Z
Image
data:image/webp;base64,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
Ipo Date
2021-03-08T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-48642000
Operating Income
48642000
Interest Expense
-
Pretax Income
-11694000
Net Income
-11686000
Eps
-0.13706296124234543
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
8000
EBITDA
-10454500
Operating Margin
-
Total Other Income Expense Net
-60336000
Cash
3329000
Short Term Investments
68882000
Receivables
-
Inventories
-
Total Current Assets
77100000
Property Plant Equipment
27122000
Total Assets
104694000
Payables
3055000
Short Term Debt
1119000
Long Term Debt
6153000
Total Liabilities
27110000
Equity
77584000
Bs_currency_symbol
USD
Depreciation
275500
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-8259000
Cf_currency_symbol
USD
PE
-
PB
0.47254379008558467
ROE
-15.062383996700351
ROA
-11.162053221770112
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
0.5
Quality Investing Score
4
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-48642000
Quarters > 0 > income Statement > operating Income
48642000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-11694000
Quarters > 0 > income Statement > net Income
-11686000
Quarters > 0 > income Statement > eps
-0.13706296124234543
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
85260087
Quarters > 0 > income Statement > income Tax Expense
8000
Quarters > 0 > income Statement > EBITDA
-10454500
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-60336000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
3329000
Quarters > 0 > balance Sheet > short Term Investments
68882000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
77100000
Quarters > 0 > balance Sheet > property Plant Equipment
27122000
Quarters > 0 > balance Sheet > total Assets
104694000
Quarters > 0 > balance Sheet > payables
3055000
Quarters > 0 > balance Sheet > short Term Debt
1119000
Quarters > 0 > balance Sheet > long Term Debt
6153000
Quarters > 0 > balance Sheet > total Liabilities
27110000
Quarters > 0 > balance Sheet > equity
77584000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-11686000
Quarters > 0 > cash Flow > depreciation
275500
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-8259000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.13706296124234543
Quarters > 0 > ratios > PB
0.47254379008558467
Quarters > 0 > ratios > ROE
-15.062383996700351
Quarters > 0 > ratios > ROA
-11.162053221770112
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
9648000
Quarters > 1 > income Statement > operating Income
-9648000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-10049000
Quarters > 1 > income Statement > net Income
-10114000
Quarters > 1 > income Statement > eps
-0.1258686511218924
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
80353606
Quarters > 1 > income Statement > income Tax Expense
65000
Quarters > 1 > income Statement > EBITDA
-9177000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-401000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
11703000
Quarters > 1 > balance Sheet > short Term Investments
67996000
Quarters > 1 > balance Sheet > receivables
2525000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
85778000
Quarters > 1 > balance Sheet > property Plant Equipment
24713000
Quarters > 1 > balance Sheet > total Assets
110954000
Quarters > 1 > balance Sheet > payables
2397000
Quarters > 1 > balance Sheet > short Term Debt
1080000
Quarters > 1 > balance Sheet > long Term Debt
6033000
Quarters > 1 > balance Sheet > total Liabilities
24331000
Quarters > 1 > balance Sheet > equity
86623000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-10114000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
7026000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.1258686511218924
Quarters > 1 > ratios > PB
0.39887848008034815
Quarters > 1 > ratios > ROE
-11.675882848666058
Quarters > 1 > ratios > ROA
-9.115489301872849
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
9308000
Quarters > 2 > income Statement > operating Income
-9308000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-8592000
Quarters > 2 > income Statement > net Income
-8691000
Quarters > 2 > income Statement > eps
-0.12336251730052493
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
70450897
Quarters > 2 > income Statement > income Tax Expense
99000
Quarters > 2 > income Statement > EBITDA
-9308000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
716000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
5019000
Quarters > 2 > balance Sheet > short Term Investments
46617000
Quarters > 2 > balance Sheet > receivables
1938000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
56786000
Quarters > 2 > balance Sheet > property Plant Equipment
23703000
Quarters > 2 > balance Sheet > total Assets
80928000
Quarters > 2 > balance Sheet > payables
2577000
Quarters > 2 > balance Sheet > short Term Debt
1001000
Quarters > 2 > balance Sheet > long Term Debt
5472000
Quarters > 2 > balance Sheet > total Liabilities
24603000
Quarters > 2 > balance Sheet > equity
56325000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-8691000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-8748000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.12336251730052493
Quarters > 2 > ratios > PB
0.5378408470483799
Quarters > 2 > ratios > ROE
-15.430093209054593
Quarters > 2 > ratios > ROA
-10.739175563463819
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
10274000
Quarters > 3 > income Statement > operating Income
-10274000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-9474000
Quarters > 3 > income Statement > net Income
-9476000
Quarters > 3 > income Statement > eps
-0.1351930857154124
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
70092342
Quarters > 3 > income Statement > income Tax Expense
2000
Quarters > 3 > income Statement > EBITDA
-5397500
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
800000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
13724000
Quarters > 3 > balance Sheet > short Term Investments
45876000
Quarters > 3 > balance Sheet > receivables
332000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
64229000
Quarters > 3 > balance Sheet > property Plant Equipment
21543000
Quarters > 3 > balance Sheet > total Assets
86204000
Quarters > 3 > balance Sheet > payables
3531000
Quarters > 3 > balance Sheet > short Term Debt
2021999
Quarters > 3 > balance Sheet > long Term Debt
5561000
Quarters > 3 > balance Sheet > total Liabilities
23538000
Quarters > 3 > balance Sheet > equity
62666000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-9476000
Quarters > 3 > cash Flow > depreciation
275500
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
8251000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.1351930857154124
Quarters > 3 > ratios > PB
0.48095788880732776
Quarters > 3 > ratios > ROE
-15.121437462100662
Quarters > 3 > ratios > ROA
-10.992529348986126
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1102000
Annuals > 0 > income Statement > gross Profit
-1102000
Annuals > 0 > income Statement > operating Expenses
34940000
Annuals > 0 > income Statement > operating Income
-36042000
Annuals > 0 > income Statement > interest Expense
344000
Annuals > 0 > income Statement > pretax Income
-31744000
Annuals > 0 > income Statement > net Income
-31750000
Annuals > 0 > income Statement > eps
-0.454041257492074
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
69927566
Annuals > 0 > income Statement > income Tax Expense
6000
Annuals > 0 > income Statement > EBITDA
-30298000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
4298000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
13724000
Annuals > 0 > balance Sheet > short Term Investments
45876000
Annuals > 0 > balance Sheet > receivables
332000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
64229000
Annuals > 0 > balance Sheet > property Plant Equipment
21543000
Annuals > 0 > balance Sheet > total Assets
86204000
Annuals > 0 > balance Sheet > payables
3531000
Annuals > 0 > balance Sheet > short Term Debt
2021999
Annuals > 0 > balance Sheet > long Term Debt
5561000
Annuals > 0 > balance Sheet > total Liabilities
23538000
Annuals > 0 > balance Sheet > equity
62666000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-31750000
Annuals > 0 > cash Flow > depreciation
1102000
Annuals > 0 > cash Flow > change In Working Capital
1168000
Annuals > 0 > cash Flow > cash From Operations
-19783000
Annuals > 0 > cash Flow > capital Expenditures
2238000
Annuals > 0 > cash Flow > cash From Investing
20768000
Annuals > 0 > cash Flow > cash From Financing
25000
Annuals > 0 > cash Flow > net Change In Cash
1170000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.454041257492074
Annuals > 0 > ratios > PB
0.37939827721571506
Annuals > 0 > ratios > ROE
-50.66543261098523
Annuals > 0 > ratios > ROA
-36.831237529580996
Annuals > 0 > ratios > FCF
-22021000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1074000
Annuals > 1 > income Statement > gross Profit
-1074000
Annuals > 1 > income Statement > operating Expenses
34606000
Annuals > 1 > income Statement > operating Income
35680000
Annuals > 1 > income Statement > interest Expense
39000
Annuals > 1 > income Statement > pretax Income
-29141000
Annuals > 1 > income Statement > net Income
-29157000
Annuals > 1 > income Statement > eps
-0.4202633800418525
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
69377922
Annuals > 1 > income Statement > income Tax Expense
16000
Annuals > 1 > income Statement > EBITDA
-28028000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
6539000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
12657000
Annuals > 1 > balance Sheet > short Term Investments
69131000
Annuals > 1 > balance Sheet > receivables
19000
Annuals > 1 > balance Sheet > inventories
-19000
Annuals > 1 > balance Sheet > total Current Assets
85756000
Annuals > 1 > balance Sheet > property Plant Equipment
21161000
Annuals > 1 > balance Sheet > total Assets
107388000
Annuals > 1 > balance Sheet > payables
2566000
Annuals > 1 > balance Sheet > short Term Debt
2124000
Annuals > 1 > balance Sheet > long Term Debt
5610000
Annuals > 1 > balance Sheet > total Liabilities
22913000
Annuals > 1 > balance Sheet > equity
84475000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-29157000
Annuals > 1 > cash Flow > depreciation
1074000
Annuals > 1 > cash Flow > change In Working Capital
2492000
Annuals > 1 > cash Flow > cash From Operations
-17958000
Annuals > 1 > cash Flow > capital Expenditures
6401000
Annuals > 1 > cash Flow > cash From Investing
18682000
Annuals > 1 > cash Flow > cash From Financing
5297000
Annuals > 1 > cash Flow > net Change In Cash
9123000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.4202633800418525
Annuals > 1 > ratios > PB
0.27923638330867123
Annuals > 1 > ratios > ROE
-34.51553714116603
Annuals > 1 > ratios > ROA
-27.151078332774613
Annuals > 1 > ratios > FCF
-24359000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
979000
Annuals > 2 > income Statement > gross Profit
-979000
Annuals > 2 > income Statement > operating Expenses
32136000
Annuals > 2 > income Statement > operating Income
-32136000
Annuals > 2 > income Statement > interest Expense
1769000
Annuals > 2 > income Statement > pretax Income
-33742000
Annuals > 2 > income Statement > net Income
-33762000
Annuals > 2 > income Statement > eps
-0.5313931915345705
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
63534875
Annuals > 2 > income Statement > income Tax Expense
20000
Annuals > 2 > income Statement > EBITDA
-31157000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1606000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5836000
Annuals > 2 > balance Sheet > short Term Investments
98694000
Annuals > 2 > balance Sheet > receivables
32000
Annuals > 2 > balance Sheet > inventories
-1065000
Annuals > 2 > balance Sheet > total Current Assets
106477000
Annuals > 2 > balance Sheet > property Plant Equipment
13281000
Annuals > 2 > balance Sheet > total Assets
120149000
Annuals > 2 > balance Sheet > payables
1423000
Annuals > 2 > balance Sheet > short Term Debt
669000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
14492000
Annuals > 2 > balance Sheet > equity
105657000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-33762000
Annuals > 2 > cash Flow > depreciation
979000
Annuals > 2 > cash Flow > change In Working Capital
-307000
Annuals > 2 > cash Flow > cash From Operations
-23879000
Annuals > 2 > cash Flow > capital Expenditures
904000
Annuals > 2 > cash Flow > cash From Investing
-89936000
Annuals > 2 > cash Flow > cash From Financing
96905000
Annuals > 2 > cash Flow > net Change In Cash
-17168000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.5313931915345705
Annuals > 2 > ratios > PB
0.2044526865233728
Annuals > 2 > ratios > ROE
-31.95434282631534
Annuals > 2 > ratios > ROA
-28.100109031286152
Annuals > 2 > ratios > FCF
-24783000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
776000
Annuals > 3 > income Statement > gross Profit
-776000
Annuals > 3 > income Statement > operating Expenses
13790000
Annuals > 3 > income Statement > operating Income
-13790000
Annuals > 3 > income Statement > interest Expense
12698000
Annuals > 3 > income Statement > pretax Income
-27264000
Annuals > 3 > income Statement > net Income
-27271000
Annuals > 3 > income Statement > eps
-0.6728776565016683
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
40528913
Annuals > 3 > income Statement > income Tax Expense
7000
Annuals > 3 > income Statement > EBITDA
-13014000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-13474000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
23236000
Annuals > 3 > balance Sheet > short Term Investments
8080000
Annuals > 3 > balance Sheet > receivables
480000
Annuals > 3 > balance Sheet > inventories
-8169000
Annuals > 3 > balance Sheet > total Current Assets
32641000
Annuals > 3 > balance Sheet > property Plant Equipment
7546000
Annuals > 3 > balance Sheet > total Assets
42215000
Annuals > 3 > balance Sheet > payables
1203000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
76992000
Annuals > 3 > balance Sheet > equity
-34777000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-27271000
Annuals > 3 > cash Flow > depreciation
776000
Annuals > 3 > cash Flow > change In Working Capital
585000
Annuals > 3 > cash Flow > cash From Operations
-11812000
Annuals > 3 > cash Flow > capital Expenditures
2927000
Annuals > 3 > cash Flow > cash From Investing
19273000
Annuals > 3 > cash Flow > cash From Financing
111000
Annuals > 3 > cash Flow > net Change In Cash
7680000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.6728776565016683
Annuals > 3 > ratios > PB
-0.39623401731029134
Annuals > 3 > ratios > ROE
78.41676970411478
Annuals > 3 > ratios > ROA
-64.60026057088713
Annuals > 3 > ratios > FCF
-14739000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.13706296124234543
Valuation > metrics > PB
0.47254379008558467
Valuation > final Score
70
Valuation > verdict
52.7% Undervalued
Profitability > metrics > ROE
-15.062383996700351
Profitability > metrics > ROA
-15.156939040207524
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3494277170550629
Risk > metrics > Interest Coverage
39.24324324324324
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
18.471490177287972
Liquidity > metrics > Quick Ratio
18.471490177287972
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
16
Prev Risks > 1
8
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:43:55.112Z
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARecap Report: What’s the beta of NESR stock - July 2025 Macro Moves & Verified Trade Idea Suggestions baoquankhu1.vn
Read more →Is This a Bottoming Phase for Life Insurance Corporation of India - Earnings Overview Report & Free Expert Approved Momentum Trade Ideas bollywoodhelpline.com
Read more →Showing 2 of 7
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Alpha Tau Medical Ltd. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.